Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Prof Rehwinkel, who has been awarded a £200,000 Lister Institute Research Prize Fellowship to study “Z-RNA and Z-DNA: Novel Inducers of Antiviral Immunity”.

Talking about his research, Prof Rehwinkel said: “In addition to the well-known B- and A-form, double-stranded DNA and RNA can also adopt the so-called Z-conformation. Physiological functions of Z-DNA and Z-RNA are incompletely understood. A clue to their potential biological roles is the observation that Z-alpha and Z-beta domains, which specifically bind to Z-DNA and Z-RNA, are found in four proteins that are all involved in innate antiviral immunity. This suggests an important role of Z-DNA and/or Z-RNA in innate antiviral immune responses. We hypothesize that nucleic acids in Z-conformation are generated specifically in virus-infected cells and are a novel pathogen-associated molecular pattern (PAMP) detected by proteins containing Z-alpha and Z-beta domains. This award will allow us to test this idea for ZBP1 (Z-DNA binding protein 1).”

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

Survey results: Reconciling work, private and family life during the COVID-19 pandemic at the Radcliffe Department of Medicine

Mark Evans, Joint Chair of the RDM Environment and Culture working group (EACWG), presents the findings of the EACWG Staff Survey, and remembers how it came about in the midst of the pandemic.